Document Detail

Xamoterol monotherapy in heart failure. The European 'Corwin' Group.
MedLine Citation:
PMID:  1971596     Owner:  NLM     Status:  MEDLINE    
The effect of xamoterol as sole therapy was investigated in randomized, double-blind, placebo-controlled studies involving 425 patients with mild to moderate heart failure. When compared with placebo, xamoterol produced improvements in exercise capacity, clinical signs, symptoms and quality of life with a low incidence of adverse experiences. Xamoterol is effective as monotherapy in heart failure.
R M Timewell; R D Stark; H F Marlow
Related Documents :
12681236 - Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure.
24028996 - Quantitative localization of premature ventricular contractions using myocardial activa...
17577106 - The pparalpha activator fenofibrate slows down the progression of the left ventricular ...
6837606 - Cardiac failure in addison's disease.
2260336 - Toxic carbamazepine concentrations following cardiothoracic surgery and myocardial infa...
19997056 - Direct cardiac effects of dobutamine, dopamine, epinephrine, and levosimendan in isolat...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  European heart journal     Volume:  11 Suppl A     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  1990 Apr 
Date Detail:
Created Date:  1990-07-05     Completed Date:  1990-07-05     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  62-4     Citation Subset:  IM    
ICI Pharmaceuticals, Macclesfield, Cheshire, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Agonists / adverse effects,  therapeutic use*
Cardiac Output, Low / drug therapy*
Double-Blind Method
Drug Evaluation
Propanolamines / adverse effects,  therapeutic use*
Randomized Controlled Trials as Topic
Reg. No./Substance:
0/Adrenergic beta-Agonists; 0/Propanolamines; 81801-12-9/Xamoterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of xamoterol on haemodynamics and plasma catecholamines in chronic heart failure.
Next Document:  A patient-powered treadmill--a simple alternative means of assessing heart failure and treatment in ...